Delivery Order SPE2DB22D2206-SPE2DB25FJE75
- Not listed
- The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,667,233 Indomethacin 50 mg suppositories. The contract, which does not have a set-aside designation, has a completion date of February 15, 2024 and a potential value of $7,956.19. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,539.80, is for the delivery of Indomethacin 50 mg suppositories. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of July 8, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,183.86, is for the provision of 4567369557 INDOMETHACIN 50 MG SUPPOSITORY 30S to support military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $85,428.62, is for the delivery of Indomethacin 50 mg suppositories. The contract is a Delivery Order and is priced on a Firm Fixed Price basis. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This federal contract award is for the delivery of INDOCIN 50 MG SUPPOSITORY 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $9,100.00, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with the DLA Troop Support Medical. The IDC, valued at $999,999,999, serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $43,623.36 to AmerisourceBergen Drug Corp on August 9, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, was competitively awarded with no set-aside designation. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where AmerisourceBergen maintains...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order valued at $31,060.98 from the Defense Logistics Agency's Medical Supply Chain on July 28, 2025. This firm fixed-price contract, which is a child order under a larger indefinite delivery contract, has an ultimate completion date of July 29, 2025 and involves pharmaceutical and medical supply deliveries to support federal healthcare...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $79,551.44 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price contract, issued without a set-aside designation through competitive procedures, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $17,524.44 to AmerisourceBergen Drug Corp on July 27, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,751.04 to AmerisourceBergen Drug Corp on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price, competitively awarded contract (No. 4568924057) represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The vendor, headquartered in Conshohocken, Pennsylvania, will perform services at its corporate office...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJE75Delivery Order
The Defense Logistics Agency awarded a $17,659.45 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Indomethacin 50 mg suppositories (30-count units), with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates its capability to meet competitive federal procurement requirements across multiple therapeutic domains and product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.7k | 8/1/25 |